Case Study
Johnson & Johnson
Following Johnson & Johnson's $3.4 billion acquisition of Auris Health and the Monarch surgical robot platform, with up to $2.4 billion in further milestone payments dependent on performance, Attomus led a strategic review assessing the path to profitability and long-term commercial viability of the platform.
Following Johnson & Johnson's $3.4 billion acquisition of Auris Health and the Monarch surgical robot platform, with up to $2.4 billion in further milestone payments dependent on performance, Attomus led a strategic review assessing the path to profitability and long-term commercial viability of the platform.
The scale of milestone exposure and the complexity of the underlying technology platform meant the review needed to produce a plan that was not only analytically sound but executable.
Attomus led a board level strategic review, assessing the path to profitability and long-term commercial viability of the platform.
The review produced an executable plan supporting profitability and long-term commercial viability of the Monarch platform.
Next step
Discuss a requirement in confidence
If your requirement carries similar delivery, security, or stakeholder pressure, we can help you assess the right next step.